Gilead’s Foreign API Supplier Faced FDA Import Alert
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
European regulators said South Korea-based ST Pharm performed a “clean up of documents” in preparation for an inspection, results of which were shared with FDA.